Key result
Higher post-ablation LAVI linked to ~2% greater MACE risk per 1 mL/m2 increase.
Why the study?
Although the prognostic value of LAVI is established, few studies have directly compared the clinical significance of post-ablation LAVI versus LARR for predicting clinical events.
Does post-ablation left atrial volume index (LAVI) or left atrial reverse remodeling (LARR) better predict major adverse cardiovascular events in patients with persistent atrial fibrillation after first catheter ablation?
Cohort (n=365)
No
Does post-ablation left atrial volume index (LAVI) or left atrial reverse remodeling (LARR) better predict major adverse cardiovascular events in patients with persistent atrial fibrillation after first catheter ablation?
Hazard Ratio: 1.02 (95% CI 1.01–1.04)
Absolute Event Rate: 21.7% vs 8.4%
p-value: p=<0.001
Post-ablation left atrial volume index is an independent predictor of major adverse cardiovascular events in patients with persistent atrial fibrillation, whereas left atrial reverse remodeling is not.
Higher post-ablation LAVI may aid MACE risk stratification in persistent AF; leaves open LARR's added value and requires prospective validation.
Post-catheter-ablation left atrial volume index (LAVI) and left atrial reverse remodeling (LARR) predict successful sinus rhythm maintenance in patients with atrial fibrillation (AF). Although the prognostic value of LAVI has been established in prior literature, few have directly compared the clinical significance of LAVI and LARR. This study compared the significance of the post-ablation LAVI and LARR for clinical events after catheter ablation in patients ( n = 365; age 66 ± 9 years; men, 77%) with persistent AF who underwent their first catheter ablation. We calculated the LARR magnitude using the pre- and post-ablation LAVI. Post-ablation LAVI and LARR were divided into tertiles and compared the incidence of major adverse cardiovascular events (MACE: all-cause death, unplanned heart failure hospitalization, and cardiovascular hospitalization) across tertiles. Over a median follow-up of 5.2 (interquartile range 3.1–7.0) years, 57 (16%) patients experienced at least one event. MACE incidence significantly increased across ascending post-ablation LAVI tertiles (cumulative incidence [95% confidence interval]: 1st [:<38 mL/m 2 ], 8.4% [2.9–13.5] vs. 2nd [38–52 mL/m 2 ], 11.6% [5.4–17.5] vs. 3rd [> 52 mL/m 2 ], 21.7% [12.4–30.0], p < 0.001). However, MACE incidence was comparable across LARR tertiles ( p = 0.900). Multivariate analysis identified post-ablation LAVI as an independent factor associated with post-ablation MACEs but not with post-ablation LARR. To conclude, the incidence of MACE increased significantly with the increase in post-ablation LAVI, but not with post-ablation LARR.
No takes yet. Share an insight, caveat, or question.
Ishiguchi et al. (2025) conducted a cohort in persistent atrial fibrillation (n=365). Post-ablation left atrial volume index (LAVI) vs. Lower post-ablation LAVI was evaluated on Major adverse cardiovascular events (MACE: all-cause death, unplanned heart failure hospitalization, and cardiovascular hospitalization) (HR 1.02, 95% CI 1.01-1.04, p=<0.001). Higher post-ablation left atrial volume index was independently associated with an increased risk of major adverse cardiovascular events (HR 1.02 per 1 mL/m2 increase), whereas post-ablation left atrial reverse remodeling showed no significant association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: